Safety and efficacy of intravenous thrombolysis in patients with acute stroke and active cancer: retrospective cohort study

Neurol Sci. 2022 Jun;43(6):4003-4006. doi: 10.1007/s10072-022-06026-7. Epub 2022 Mar 24.

Authors

Maria Giulia Mosconi¹, Andrea Capponi², Patrizia Pierini², Valeria Caso², Maurizio Paciaroni²

Affiliations

¹ Internal, Vascular and Emergency Medicine-Stroke Unit, Università Degli Studi Di Perugia/Azienda Ospedaliera Santa Maria Della Misericordia, 06129, Perugia, Italy. mariagiulia.mosconi@unipg.it.
² Internal, Vascular and Emergency Medicine-Stroke Unit, Università Degli Studi Di Perugia/Azienda Ospedaliera Santa Maria Della Misericordia, 06129, Perugia, Italy.

PMID: 35325319
DOI: 10.1007/s10072-022-06026-7

No abstract available

Publication types

Letter

MeSH terms

Brain Ischemia* / drug therapy
Fibrinolytic Agents / adverse effects
Humans
Neoplasms* / complications
Neoplasms* / drug therapy
Retrospective Studies
Stroke* / complications
Stroke* / drug therapy
Thrombolytic Therapy / adverse effects
Tissue Plasminogen Activator / adverse effects
Treatment Outcome

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator